335 related articles for article (PubMed ID: 17579279)
21. Serum levels of soluble CD30 in adult patients affected by atopic dermatitis and its relation to age, duration of disease and Scoring Atopic Dermatitis index.
Di Lorenzo G; Gangemi S; Merendino RA; Minciullo PL; Cannavò SP; Martinelli N; Mansueto P; Rini GB; Corrocher R; Pacor ML
Mediators Inflamm; 2003 Apr; 12(2):123-5. PubMed ID: 12775363
[TBL] [Abstract][Full Text] [Related]
22. Soluble CD30 serum levels in atopic dermatitis and bronchial asthma and its relationship with disease severity in pediatric age.
Heshmat NM; El-Hadidi ES
Pediatr Allergy Immunol; 2006 Jun; 17(4):297-303. PubMed ID: 16771784
[TBL] [Abstract][Full Text] [Related]
23. The objective severity assessment of atopic dermatitis (OSAAD) score: validity, reliability and sensitivity in adult patients with atopic dermatitis.
Angelova-Fischer I; Bauer A; Hipler UC; Petrov I; Kazandjieva J; Bruckner T; Diepgen T; Tsankov N; Williams M; Fischer TW; Elsner P; Fluhr JW
Br J Dermatol; 2005 Oct; 153(4):767-73. PubMed ID: 16181458
[TBL] [Abstract][Full Text] [Related]
24. [Peripheral eosinophil counts relates the improvement of the skin lesions of atopic dermatitis patients more sensitive than serum eosinophil cationic protein levels].
Nishimoto M; Numahara T; Nakashima K; Yoshida T
Arerugi; 1998 Jun; 47(6):591-6. PubMed ID: 9721450
[TBL] [Abstract][Full Text] [Related]
25. Scoring atopic dermatitis in infants and young children: distinctive features of the SCORAD index.
Pucci N; Novembre E; Cammarata MG; Bernardini R; Monaco MG; Calogero C; Vierucci A
Allergy; 2005 Jan; 60(1):113-6. PubMed ID: 15575941
[TBL] [Abstract][Full Text] [Related]
26. Clinical improvement and immunological changes in atopic dermatitis patients undergoing subcutaneous immunotherapy with a house dust mite allergoid: a pilot study.
Bussmann C; Maintz L; Hart J; Allam JP; Vrtala S; Chen KW; Bieber T; Thomas WR; Valenta R; Zuberbier T; Sager A; Novak N
Clin Exp Allergy; 2007 Sep; 37(9):1277-85. PubMed ID: 17845407
[TBL] [Abstract][Full Text] [Related]
27. CD4(+)IL-13(+) cells in peripheral blood well correlates with the severity of atopic dermatitis in children.
La Grutta S; Richiusa P; Pizzolanti G; Mattina A; Pajno GB; Citarrella R; Passalacqua G; Giordano C
Allergy; 2005 Mar; 60(3):391-5. PubMed ID: 15679728
[TBL] [Abstract][Full Text] [Related]
28. Serum concentrations of CCR4 ligands in relation to clinical severity of atopic dermatitis in Egyptian children.
Mostafa GA; Tomoum HY; Salem SA; Abd El-Aziz MM; Abou El-Maged DI; El-Sayed El-Far I
Pediatr Allergy Immunol; 2008 Dec; 19(8):756-62. PubMed ID: 18435706
[TBL] [Abstract][Full Text] [Related]
29. Brain-derived neurotrophic factor is increased in atopic dermatitis and modulates eosinophil functions compared with that seen in nonatopic subjects.
Raap U; Goltz C; Deneka N; Bruder M; Renz H; Kapp A; Wedi B
J Allergy Clin Immunol; 2005 Jun; 115(6):1268-75. PubMed ID: 15940146
[TBL] [Abstract][Full Text] [Related]
30. Association between serum IL-16 levels and the degree of sensitization in patients with atopic dermatitis.
Nagy G; Gáspár K; Irinyi B; Gál M; Tumpek J; Gyimesi E; Sipka S; Remenyik É; Szodoray P; Szegedi A
Int Arch Allergy Immunol; 2011; 156(1):69-74. PubMed ID: 21447961
[TBL] [Abstract][Full Text] [Related]
31. Effects of tacrolimus ointment on the expression of substance P, nerve growth factor, and neurotrophin-3 in atopic dermatitis.
Kim HO; Lee CH; Ahn HK; Park CW
Int J Dermatol; 2009 Apr; 48(4):431-8. PubMed ID: 19335435
[TBL] [Abstract][Full Text] [Related]
32. Relationships among plasma granzyme B level, pruritus and dermatitis in patients with atopic dermatitis.
Kamata Y; Kimura U; Matsuda H; Tengara S; Kamo A; Umehara Y; Iizumi K; Kawasaki H; Suga Y; Ogawa H; Tominaga M; Takamori K
J Dermatol Sci; 2016 Dec; 84(3):266-271. PubMed ID: 27686401
[TBL] [Abstract][Full Text] [Related]
33. Serum levels of Th2 chemokines, CCL17, CCL22, and CCL27, were the important markers of severity in infantile atopic dermatitis.
Nakazato J; Kishida M; Kuroiwa R; Fujiwara J; Shimoda M; Shinomiya N
Pediatr Allergy Immunol; 2008 Nov; 19(7):605-13. PubMed ID: 18266834
[TBL] [Abstract][Full Text] [Related]
34. Serum levels of TNF-alpha, IFN-gamma, IL-6, IL-8, IL-12, IL-17, and IL-18 in patients with active psoriasis and correlation with disease severity.
Arican O; Aral M; Sasmaz S; Ciragil P
Mediators Inflamm; 2005 Oct; 2005(5):273-9. PubMed ID: 16258194
[TBL] [Abstract][Full Text] [Related]
35. Serum thymus and activation-regulated chemokine (TARC) and cutaneous T cell- attracting chemokine (CTACK) levels in allergic diseases: TARC and CTACK are disease-specific markers for atopic dermatitis.
Hijnen D; De Bruin-Weller M; Oosting B; Lebre C; De Jong E; Bruijnzeel-Koomen C; Knol E
J Allergy Clin Immunol; 2004 Feb; 113(2):334-40. PubMed ID: 14767451
[TBL] [Abstract][Full Text] [Related]
36. Serum levels of cutaneous T-cell attracting chemokine (CTACK) as a laboratory marker of the severity of atopic dermatitis in children.
Hon KL; Leung TF; Ma KC; Li AM; Wong Y; Fok TF
Clin Exp Dermatol; 2004 May; 29(3):293-6. PubMed ID: 15115514
[TBL] [Abstract][Full Text] [Related]
37. Psoralen-ultraviolet A therapy alters epidermal Sema3A and NGF levels and modulates epidermal innervation in atopic dermatitis.
Tominaga M; Tengara S; Kamo A; Ogawa H; Takamori K
J Dermatol Sci; 2009 Jul; 55(1):40-6. PubMed ID: 19443185
[TBL] [Abstract][Full Text] [Related]
38. Chemokine RANTES in atopic dermatitis.
Glück J; Rogala B
Arch Immunol Ther Exp (Warsz); 1999; 47(6):367-72. PubMed ID: 10608293
[TBL] [Abstract][Full Text] [Related]
39. Platelet-derived microparticles and soluble P-selectin as platelet activation markers in patients with atopic dermatitis.
Tamagawa-Mineoka R; Katoh N; Ueda E; Masuda K; Kishimoto S
Clin Immunol; 2009 Jun; 131(3):495-500. PubMed ID: 19217350
[TBL] [Abstract][Full Text] [Related]
40. Serum soluble CD26 levels: diagnostic efficiency for atopic dermatitis, cutaneous T-cell lymphoma and psoriasis in combination with serum thymus and activation-regulated chemokine levels.
Miyagaki T; Sugaya M; Suga H; Morimura S; Kamata M; Ohmatsu H; Fujita H; Asano Y; Tada Y; Kadono T; Sato S
J Eur Acad Dermatol Venereol; 2013 Jan; 27(1):19-24. PubMed ID: 22077186
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
